Access to anti-retroviral drugs, male in Tunisia
Tunisia: Access to anti-retroviral drugs, male was 28.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Tunisia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Tunisia recorded 28.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
The figure is up 12.0% on the previous year and up 211.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Tunisia peaked at 28.0% in 2024 and was at its lowest, 0.0%, in 2000.
Tunisia ranks 133rd of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Tunisia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 2.0% | — |
| 2002 | 2.0% | +0.0% |
| 2003 | 3.0% | +50.0% |
| 2004 | 3.0% | +0.0% |
| 2005 | 4.0% | +33.3% |
| 2006 | 5.0% | +25.0% |
| 2007 | 5.0% | +0.0% |
| 2008 | 6.0% | +20.0% |
| 2009 | 7.0% | +16.7% |
| 2010 | 8.0% | +14.3% |
| 2011 | 9.0% | +12.5% |
| 2012 | 7.0% | -22.2% |
| 2013 | 8.0% | +14.3% |
| 2014 | 9.0% | +12.5% |
| 2015 | 10.0% | +11.1% |
| 2016 | 12.0% | +20.0% |
| 2017 | 12.0% | +0.0% |
| 2018 | 14.0% | +16.7% |
| 2019 | 16.0% | +14.3% |
| 2020 | 17.0% | +6.2% |
| 2021 | 18.0% | +5.9% |
| 2022 | 22.0% | +22.2% |
| 2023 | 25.0% | +13.6% |
| 2024 | 28.0% | +12.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.7% | 0.0% | 7.0% | 10 |
| 2010s | 10.5% | 7.0% | 16.0% | 10 |
| 2020s | 22.0% | 17.0% | 28.0% | 5 |
Countries ranked near Tunisia
More gender data for Tunisia
- Child population (UN estimates and projections) 2,590 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.76 % change on previous year (2030)
- Population 10,039 (2030)
- Working-age population (UN estimates and projections) 10,039 (2030)
- Population (UN estimates and projections), annual growth rate 1.2 % change on previous year (2030)
- Age population, age 00, female, interpolated 78,462 (2025)
- Age population, age 00, male, interpolated 82,178 (2025)
- Age population, age 01, female, interpolated 79,945 (2025)
- Age population, age 01, male, interpolated 83,799 (2025)
- Age population, age 02, female, interpolated 81,489 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Tunisia?
- Access to anti-retroviral drugs, male in Tunisia was 28.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Tunisia?
- The highest recorded value was 28.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Tunisia?
- The lowest recorded value was 0.0% in 2000.
- How does Tunisia rank for access to anti-retroviral drugs, male?
- Tunisia ranks 133rd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Tunisia?
- Over the last ten years it is up 211.1%. The long-run trend across the full record is volatile.
- Where does this Tunisia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.